← Open Payments lookup

ERIN LAGROUE: Open Payments

NPI 1538471495 · WALKER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,292 in 121 payments from 21 companies in 2025. Trend: 2023 $2,400 · 2024 $2,139 · 2025 $2,292

Food & beverage: $2,292
CompanyPaymentsAmount
Novo Nordisk Inc13$246
GlaxoSmithKline, LLC.14$242
Bayer Healthcare Pharmaceuticals Inc.6$225
Axsome Therapeutics, Inc.12$225
PFIZER INC.11$198
Lilly USA, LLC11$180
ABBVIE INC.10$172
AstraZeneca Pharmaceuticals LP4$156
Phathom Pharmaceuticals, Inc.9$124
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$113

Products named: Kerendia, TRELEGY ELLIPTA, Auvelity, AIRSUPRA, MOUNJARO, VOQUEZNA, XIFAXAN, Ozempic.

Industry payments across LA — which companies pay providers there.